M&A Deal Summary

Medtronic Acquires Osteotech

On November 16, 2010, Medtronic acquired life science company Osteotech for 123M USD

Acquisition Highlights
  • This is Medtronic’s 1st transaction in the Life Science sector.
  • This is Medtronic’s 26th largest (disclosed) transaction.
  • This is Medtronic’s 21st transaction in the United States.
  • This is Medtronic’s 1st transaction in New Jersey.
Investment Fate
  • Osteotech was divested to a consortium of strategic buyers in 2019.

M&A Deal Summary

Date 2010-11-16
Target Osteotech
Sector Life Science
Buyer(s) Medtronic
Deal Type Add-on Acquisition
Deal Value 123M USD

Target

Osteotech

Eatontown, New Jersey, United States
Osteotech, Inc. is a provider of biologic solutions for regenerative medicine to support surgeons and their patients in the repair of the musculoskeletal system through the development of innovative therapy-driven products that alleviate pain, promote biologic healing and restore function. Osteotech was formed in 1986 and is based in Eatontown, New Jersey.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Medtronic

Galway, Ireland

Category Company
Founded 1949
Sector Medical Products
Employees95,000
Revenue 33.5B USD (2025)
DESCRIPTION
Medtronic's operational headquarters in Fridley, Minnesota.
Medtronic's operational headquarters in Fridley, Minnesota.

Medtronic is a global medical technology company whose products aim to alleviate pain, restore health, and extend life. It serves hospitals, physicians, clinicians, and patients in approximately 160 countries worldwide. Medtronic was founded in 1949 and is based in Galway, Ireland with its operational headquarters in Fridley, Minnesota.


DEAL STATS #
Overall 24 of 59
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 24 of 57
State: New Jersey M&A 1 of 2
Country: United States M&A 21 of 44
Year: 2010 M&A 3 of 3
Size (of disclosed) 26 of 36
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-04-29 ATS Medical

Minneapolis, Minnesota, United States

ATS Medical, Inc., engages in the development, manufacture and marketing of medical devices for the treatment of structural heart diseases. It offers prosthetic heart valves, such as ATS Open Pivot Heart Valve, as well as ATS 3F Aortic Bioprosthesis, a biological replacement aortic heart valve and heart valve repair products. The company also markets and sells surgical cryoablation products for the treatment of cardiac arrhythmias, and it is developing minimally invasive and off-pump aortic valve concepts.

Buy $370M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-01-13 Ardian

Mountain View, California, United States

Ardian, Inc. is a developer of catheter-based therapies to treat hypertension and related conditions. Ardian is the eighth company created by The Foundry, a leading medical device incubator.

Buy $800M